Ultime notizie per Dometic Gr (OTC:DTCGF) Azioni

Dometic Group AB provides leisure products for recreational vehicles (RV), marine and commercial and passenger vehicles (CPV) markets. It provides branded solutions for mobile living in the areas of climate, Power & Control, hygiene and sanitation, and food and beverage. It serves the market with a complete range of air conditioners, refrigerators, awnings, cookers, sanitation, lighting, mobile power equipment, windows, doors, and other comfort and safety products that make life away from home more comfortable. The group is organized into four regions, Europe, Middle East and Africa (EMEA), the Americas, Asia Pacific (APAC), and other countries.

Dometic Group AB

STORM-PE is a first-of-its-kind clinical trial comparing computer assisted vacuum thrombectomy (CAVT&#x2122;) using Penumbra's Lightning Flash&#x2122; with anticoagulation versus anticoagulation alone in the treatment of acute intermediate-high risk pulmonary embolism
ALAMEDA, Calif., June 16, 2025 /PRNewswire/ -- <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4449339-1&amp;h=4010568651&amp;u=https%3A%2F%2Fwww.penumbrainc.com%2F&amp;a=Penumbra%2C+Inc">Penumbra, Inc</a>. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PEN#NYSE">PEN</a>), the world's leading thrombectomy company, announced the completion of enrollment in the STORM-PE&nbsp;clinical trial. The pivotal, prospective, multi-center randomized controlled trial enrolled 100 patients to evaluate computer assisted vacuum thrombectomy (CAVT) using Penumbra's Lightning Flash&#x2122; plus anticoagulation, versus anticoagulation alone, for the treatment of acute intermediate-high risk pulmonary embolism (PE).

News

Penumbra Completes Enrollment In STORM-PE Clinical Trial For Treatment Of Acute Intermediate-High Risk Pulmonary Embolism

Movers

Trading Ideas

Meta Shares Move Higher, Seeing Reports Indicating Co. Introduces Channel Subscriptions, Promoted Channels And Ads In Status In WhatsApp Updates Tab

Barclays analyst Lauren Lieberman maintains Primo Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRMB#NYSE">PRMB</a>) with a Overweight and lowers the price target from $40 to $38.

Price Target

Analyst Ratings

PRMB

Barclays Maintains Overweight on Primo Brands, Lowers Price Target to $38

<a href="https://pr.report/bjew">WidePoint Corporation</a><a href="https://pr.report/bjex">(NYSE:</a><a href="https://www.benzinga.com/stock/WYY#NYSE">WYY</a>), the federally certified provider of Trusted Mobility Management (TM2) solutions, announced today that it has secured a three-year deal valued at $1.06 million to deliver External Certification Authority (ECA) Token Certificate credentials to a top-tier, U.S.-based aerospace and defense contractor. This transaction underscores WidePoint's ongoing commitment to supporting the secure identity management needs of mission-critical national security partners.

WidePoint Secures 3-Yr Deal Valued At $1.06M To Deliver External Certification Authority Token Certificate Credentials To U.S.-Based Aerospace And Defense Contractor

Robin Energy Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RBNE#NASDAQ">RBNE</a>) ("Robin Energy" or the "Company"), an international ship-owning company providing energy transportation services globally, today announced that it has entered into a securities purchase agreement with several institutional investors to purchase 965,000 common shares at an offering price of $5.25, for gross proceeds of approximately $5.1 million (the "Offering"), before deducting commissions and offering expenses, in a registered direct offering priced at-the-market under Nasdaq rules.
Maxim Group LLC is acting as the sole placement agent for the Offering.

Offerings

RBNE

Robin Energy Announces $5.1M At-the-Market Registered Direct Offering Of 965,000 Shares At $5.25 Per Share

Cohen & Steers Invests $300M In Hudson Pacific Properties To Support HPP's Balance Sheet Recapitalization; Purchase Reflects 43% Of HPP's $690M Offering

Reitar Logtech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RITR#NASDAQ">RITR</a>) (the "Company", and together with its subsidiaries, the "Group") has officially launched a Bitcoin acquisition program of up to US$1.5 billion (approximately HKD 11.77 billion), which will be paid for with the Company's ordinary shares. According to the Bitcoin reserve strategy, the Group is planning to issue a digital token — "RBTC" — pegged to Bitcoin as the underlying asset. The Company expects this token to be fully supported by 100% Bitcoin reserves, achieving a 1:1 Bitcoin exchange rate. Clients can exchange "RBTC" using Hong Kong dollars or US dollars and can pay for storage rent, value-added services, Warehouse as a Service (WaaS) and related service fees at discounted rates in all smart warehouses under the Reitar Logtech Group, further promoting the digitalization, intelligence, and transparency of the warehousing payment process and facilitating the upgrade of smart logistics.
Meanwhile, in line with the HKSAR Government's passage of the Stablecoin bill on 21 May, which will be implemented on 1 August, the Company is actively studying the relevant regulatory details and plans to apply for a Hong Kong stablecoin issuer license after the legislation comes into effect, launching its own stablecoin "RHKD." This stablecoin will mainly be used for payments and settlements in cross-border e-commerce, logistics, and supply chains. Through blockchain, all transactions can be recorded on-chain, facilitating the auditing and tracking of fund flows and goods flows, and can incorporate smart contracts to automatically handle payment scenarios such as "cash on delivery," comprehensively enhancing capital efficiency and promoting internal transactions of goods within warehouses. This enables the smart warehouse network within Reitar to not only possess traditional storage functions but also become a center for goods transactions. Additionally, the "RHKD" stablecoin can seamlessly connect with various digital payment platforms and supply chain financial products, providing greater flexibility and convenience for businesses and clients, aiding in the digital upgrade of the industry.
The Company will uphold the principles of compliance, innovation, and professionalism, actively cooperating with regulatory requirements, and partnering with industry stakeholders to build an intelligent, transparent, and efficient logistics financial ecosystem, promoting high-quality development of the Guangdong-Hong Kong-Macao Greater Bay Area and the Asian supply chain.
About Reitar Logtech Reitar Logtech Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RITR#NASDAQ">RITR</a>) went public on the NASDAQ in 2024 and is the first comprehensive industry solution provider in Asia focused on "Property + Logistics Technology" (PLT). As an industry pioneer in innovation, the group is committed to the full life cycle management of logistics assets and technology empowerment, building an integrated platform covering investment development, operational management, and digital transformation. Reitar drives innovation through "asset value enhancement" and "technology application," effectively achieving synergistic growth in clients' asset operational efficiency and economic benefits while promoting the efficient allocation and cross-industry integration of logistics industry resources.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Markets

RITR

Reitar Logtech Announces It Has Officially Launched A Bitcoin Acquisition Program Of Up To $1.5B

Spotify (SPOT) is currently in its 10th Phase out of the 18-phase Adhishthana Cycle. While the stock has been extremely bullish lately, some key dates ahead could mark a potential peak. Here&#8217;s why.
<h3 class="wp-block-heading">Spotify's Cycle So Far</h3>
So far, Spotify has maintained a strong 88.88% alignment with the Adhishthana Principles, our cyclical framework that combines proprietary behavioral archetypes, quantitative signals, and timing structures.
Here are some notable alignment milestones:
<h4 class="wp-block-heading">Phase 2: The Rally of Buddhi</h4>
<figure class="wp-block-image size-full is-resized"><img loading="lazy" decoding="async" width="712" height="396" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/16095249/Spotify-Phase-2-Adhishthana.png" alt="Fig.1 Spotify Phase 2 (Source: Adhishthana.com)" class="wp-image-14439" style="width:471px;height:auto" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/16095249/Spotify-Phase-2-Adhishthana.png 712w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/16095249/Spotify-Phase-2-Adhishthana-300x167.png 300w" sizes="(max-width: 712px) 100vw, 712px" /><figcaption class="wp-element-caption">Fig.1 Spotify Phase 2 (Source: Adhishthana.com)</figcaption></figure>
As outlined in the Adhishthana Principles, Phase 2 often begins with a prolonged consolidation followed by an explosive move. Spotify mirrored this pattern precisely trading in a range for 38 bars before launching a powerful Buddhi rally that resulted in a ~155% gain.
<h4 class="wp-block-heading">Phases 4 to 8: The Creation of the Cakra</h4>
<figure class="wp-block-image size-full is-resized"><img loading="lazy" decoding="async" width="1200" height="529" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/16095407/Spotify-Cakra-Formation.png" alt="Fig.2 Spotify Cakra Formation (Source: Adhishthana.com)" class="wp-image-14443" style="width:661px;height:auto" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/16095407/Spotify-Cakra-Formation.png 1200w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/16095407/Spotify-Cakra-Formation-300x132.png 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/16095407/Spotify-Cakra-Formation-1024x451.png 1024w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/16095407/Spotify-Cakra-Formation-768x339.png 768w" sizes="(max-width: 1200px) 100vw, 1200px" /><figcaption class="wp-element-caption">Fig.2 Spotify Cakra Formation (Source: Adhishthana.com)</figcaption></figure>
From Phase 4 through Phase 8, Spotify formed what we define as the Cakra—a distinct structural curve that respects both the upper and lower bounds of its cyclical geometry. Each phase aligned well with the lower band of the Cakra, reinforcing the stock's bullish foundation.
<h4 class="wp-block-heading">Phase 9: The Supreme Breakout</h4>
<figure class="wp-block-image size-full is-resized"><img loading="lazy" decoding="async" width="1200" height="740" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/16095442/Spotify-Phase-9-Adhishthana.png" alt="Fig.3 Spotify Phase 9 (Source: Adhishthana.com)" class="wp-image-14444" style="width:611px;height:auto" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/16095442/Spotify-Phase-9-Adhishthana.png 1200w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/16095442/Spotify-Phase-9-Adhishthana-300x185.png 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/16095442/Spotify-Phase-9-Adhishthana-1024x631.png 1024w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/16095442/Spotify-Phase-9-Adhishthana-768x474.png 768w" sizes="(max-width: 1200px) 100vw, 1200px" /><figcaption class="wp-element-caption">Fig.3 Spotify Phase 9 (Source: Adhishthana.com)</figcaption></figure>
According to the Adhishthana model, Phase 9 is often when the breakout move, the &#8220;Supreme Move&#8221; occurs, provided the Cakra is complete. Spotify delivered exactly that, surging by approximately 84.84% during this period.
<h3 class="wp-block-heading">What's Next?</h3>
Now in Phase 10, Spotify is in the critical phase that tests whether its Adhishthana Himalayan Formation&#8217;s ascent will continue or pause.
In our framework, peak formation typically occurs around the 18th or 23rd bar of Phase 10. For Spotify, that timing translates to 15 September to 20 October 2025.
<ul class="wp-block-list">
<li>If a peak begins forming during this window, a descent may follow—potentially revisiting mid-to-low levels of Phase 9. </li>
<li>If no reversal is seen, the stock may continue its ascent into Phase 11, beginning 9 March 2026. </li>
</ul>
<h3 class="wp-block-heading">A Word of Caution on the Monthly Charts</h3>
While the weekly charts are bullish, the monthly charts provide a more nuanced view. On the monthly timeframe, Spotify is in its Phase 2 (Buddhi Period). Although this phase is typically associated with strong rallies, it only performs reliably when it follows a bearish or consolidated Sankhya Move, which did not materialize in the case of Spotify.
This increases the probability that a peak may occur either late in Phase 10 or early in Phase 11 on the weekly charts.
<h3 class="wp-block-heading">Final Call for Investors</h3>
<ul class="wp-block-list">
<li>Watch the window between 15 September and 20 October 2025 closely for signs of a potential top. If a peak forms, expect a corrective wave to follow. Existing longs should manage risk and trail stops accordingly. </li>
<li>New entries should be avoided until a correction confirms itself and a new accumulation phase begins. </li>
</ul>
While the rally has been strong and technically sound, the principles advise caution over complacency as Spotify approaches a possible cyclical turning point.

Equities

Technicals

Opinion

Signals

Spotify: What's Driving the Rally, Key Dates To Watch

<a href="https://www.theinformation.com/articles/doordash-ubers-behind-scenes-delivery-battles" title="https://www.theinformation.com/articles/doordash-ubers-behind-scenes-delivery-battles">https://www.theinformation.com/articles/doordash-ubers-behind-scenes-delivery-battles</a>

DASH

UBER

'DoorDash and Uber's Behind-the-Scenes Delivery Battles' - The Information

Biotech

General

ABBV

AbbVie Says Phase 3 VERONA Trial In Newly Diagnosed Higher-Risk Myelodysplastic Syndromes Did Not Meet Primary Endpoint Of Overall Survival

As global tensions in the Middle East highlight a volatility in the oil markets, an expert suggests the U.S. economy&#8217;s susceptibility to oil price shocks has significantly diminished compared to previous decades.
What Happened: According to Bob Elliott, the CIO of Unlimited Funds, the shift in the mechanical impact of rising oil prices is primarily due to the United States&#8217; transition into a net exporter of crude products.
Traditionally, oil price surges acted as a significant drag on household spending and often prompted central banks to adopt tighter monetary policies to combat inflation. However, Elliott&#8217;s detailed examination reveals a changed landscape.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">The US economy is far less sensitive to an oil shock than in previous decades. While the ongoing Mideast conflict is a concern, it would take multiples of the the impact priced in so far to have meaningful economic impact. Thread.
&mdash; Bob Elliott (@BobEUnlimited) <a href="https://twitter.com/BobEUnlimited/status/1934558230123782446?ref_src=twsrc%5Etfw">June 16, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
While consumer gasoline prices might still see a moderate uptick following price increases, the overall impact on household consumption is far less profound. Spending on fuel has fallen to a mere 1.3% of total household consumption, making recent price movements &#8220;not noticeable&#8221; in the broader economic context, Eliott explains.
&#8220;The surge in US production to the point where the US is a net exporter highlights how an oil shock may not be nearly as detrimental as in past rounds. While it would create a drag on HH consumption and rising inflation, it will also support domestic production &amp; investment,&#8221; he said in an X thread.
Furthermore, the surge in domestic oil production means that higher prices now generate increased income for U.S. oil producers, offsetting some of the drag felt elsewhere. This domestic boost in income and the incentive for greater production efforts highlight a crucial difference in the economic equation.
Here&#8217;s a list of a few U.S. oil producers and oil ETFs.
<figure class="wp-block-table is-style-stripes"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Listed Oil Companies</td>
<td>Friday&#8217;s Performance</td>
<td>YTD Performance</td>
<td>One-Year Performance</td>
</tr>
<tr>
<td>Exxon Mobil Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XOM#NYSE">XOM</a>)</td>
<td>2.18%</td>
<td>4.48%</td>
<td>3.47%</td>
</tr>
<tr>
<td>Chevron Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVX#NYSE">CVX</a>)</td>
<td>0.65%</td>
<td>-0.55%</td>
<td>-4.75%</td>
</tr>
<tr>
<td>Occidental Petroleum Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OXY#NYSE">OXY</a>)</td>
<td>3.78%</td>
<td>-6.75%</td>
<td>-22.84%</td>
</tr>
<tr>
<td>EOG Resources Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EOG#NYSE">EOG</a>)</td>
<td>3.89%</td>
<td>0.46%</td>
<td>5.21%</td>
</tr>
<tr>
<td>Marathon Petroleum Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPC#NYSE">MPC</a>)</td>
<td>0.65%</td>
<td>17.43%</td>
<td>-3.25%</td>
</tr>
<tr>
<td>CVR Energy Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVI#NYSE">CVI</a>)</td>
<td>4.95%</td>
<td>43.50%</td>
<td>-0.37%</td>
</tr>
<tr>
<td>Schlumberger NV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLB#NYSE">SLB</a>)</td>
<td>1.88%</td>
<td>-5.47%</td>
<td>-16.80%</td>
</tr>
</tbody>
</table>
</figure>
<figure class="wp-block-table is-style-stripes"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Listed Oil ETFs</td>
<td>Friday&#8217;s Performance</td>
<td>YTD Performance</td>
<td>One-Year Performance</td>
</tr>
<tr>
<td>United States Oil Fund LP (ARCA&#8221; USO)</td>
<td>6.89%</td>
<td>4.28%</td>
<td>4.28%</td>
</tr>
<tr>
<td>ProShares Ultra Bloomberg Crude Oil (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UCO#NYSE">UCO</a>)</td>
<td>8.65%</td>
<td>-7.44%</td>
<td>-19.06%</td>
</tr>
<tr>
<td>SPDR S&amp;P Oil &amp; Gas Exploration &amp; Production ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XOP#NYSE">XOP</a>)</td>
<td>2.67%</td>
<td>-1.51%</td>
<td>-6.96%</td>
</tr>
</tbody>
</table>
</figure>
See Also: <a href="https://www.benzinga.com/markets/forex/25/06/45943600/is-us-dollar-losing-its-edge-de-dollarization-and-fading-exceptionalism-raise-alarms">Is US Dollar Losing Its Edge? De-Dollarization And Fading Exceptionalism Raise Alarms</a>
Why It Matters: Despite escalating conflict, Iran has notably reduced its missile barrages on Israel, with the Institute for the Study of War (ISW) attributing this to the effectiveness of Israeli airstrikes.
Early waves on Friday and Saturday saw Iran launching 100-200 missiles per wave. However, subsequent attacks have <a href="https://www.benzinga.com/markets/equities/25/06/45944854/irans-missile-stockpile-may-be-shrinking-as-strikes-on-israel-taper-off-says-think-tank-lmt-rtx-gd-in-focus">dropped to 35-40 missiles each</a>, indicating a significant impact on Iran&#8217;s launch capacity. 
Initial estimates placed Iran&#8217;s missile stockpile at around 2,000, with an alleged plan to fire 1,000 ballistic missiles. Yet, Israeli strikes reportedly damaged or destroyed numerous launchers and silos, limiting Iran to just 200 launches. This suggests Iran may soon face difficulties sustaining its current missile attack rate.
Price Action: As of the publication of this article, Crude Oil WTI Futures were 1.32% lower at $70.47, and Brent Oil was down 1.24% to $73.31.
The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which track the S&amp;P 500 index and Nasdaq 100 index, respectively, rose in premarket on Monday. The SPY was up 0.50% at $599.99, while the QQQ advanced 0.56% to $529.93, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/25/06/45921978/ibm-google-emerge-as-top-investors-in-quantum-computing-with-most-patents-issued-in-2025-only-two-co" target="_blank" rel="noreferrer noopener">IBM, Google Emerge As Top Investors In Quantum Computing With Most Patents Issued In 2025: ‘Only Two Companies Seriously Investing,' Says Martin Shkreli</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors. 
Image Via Shutterstock

Exxon Mobil, Chevron, Occidental Petroleum In Focus As Expert Says 'US Economy Is Far Less Sensitive To An Oil Shock' Amid Israel-Iran Conflict

Can-Fite BioPharma Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CANF#NYSE">CANF</a>) (TASE: CANF), a clinical-stage biotechnology company developing a pipeline of proprietary small molecule drugs for the treatment of cancer and inflammatory diseases, today announced that Dr. Sari Fishman, Vice President of Business Development, will present an update on the Company's ongoing Phase IIa study in pancreatic cancer during partnering meetings at the 2025 BIO International Convention, taking place June 16–19 in Boston, MA (<a href="https://www.globenewswire.com/Tracker?data=5E6zrGyBgyFSauzvrk8eIvxhuwBIsF-7Tw4YQdEM4tn0cm-ECWXUgYcvmwZmbj8CT_R_E1E_x121CMefjfTMMcUaGlhVkq4DED8f-kb2UI8=">link</a>).
The Phase IIa clinical trial is open-label study evaluating Namodenoson in patients with advanced pancreatic adenocarcinoma whose disease has progressed following at least one prior line of therapy. The study is assessing the safety, clinical activity, and pharmacokinetics (PK) of Namodenoson, administered orally at a dose of 25 mg twice daily in continuous 28-day cycles. Approximately 20 evaluable patients are expected to be enrolled.
Can-Fite looks forward to engaging with potential partners and collaborators at BIO 2025 as it continues to progress its clinical pipeline.

CANF

Can-Fite BioPharma To Present Update On Ongoing Phase Iia Study In Pancreatic Cancer During Partnering Meetings At 2025 BIO International Convention

CNTA

Centessa Pharmaceuticals Receives FDA Clearance Of Investigational New Drug Application For ORX142, With Clinical Data In Acutely Sleep-Deprived Healthy Volunteers Planned For this Year

JP Morgan analyst Matthew Boss maintains Abercrombie &amp; Fitch (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ANF#NYSE">ANF</a>) with a Overweight and lowers the price target from $147 to $141.

JP Morgan Maintains Overweight on Abercrombie & Fitch, Lowers Price Target to $141

Across the recent three months, 9 analysts have shared their insights on Freeport-McMoRan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FCX#NYSE">FCX</a>), expressing a variety of opinions spanning from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">5</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">4</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $45.56, with a high estimate of $52.00 and a low estimate of $39.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 3.31%. 
<img src="https://www.benzinga.com/files/images/story/2025/1750078837_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
The standing of Freeport-McMoRan among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Orest Wowkodaw</td>
<td>Scotiabank</td>
<td>Raises</td>
<td>Sector Outperform</td>
<td>$48.00</td>
<td>$43.00</td>
</tr>
<tr>
<td>Orest Wowkodaw</td>
<td>Scotiabank</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$43.00</td>
<td>$40.00</td>
</tr>
<tr>
<td>Chris LaFemina</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Buy</td>
<td>$50.00</td>
<td>$48.00</td>
</tr>
<tr>
<td>Timna Tanners</td>
<td>Wolfe Research</td>
<td>Announces</td>
<td>Outperform</td>
<td>$39.00</td>
<td>-</td>
</tr>
<tr>
<td>Daniel Major</td>
<td>UBS</td>
<td>Lowers</td>
<td>Buy</td>
<td>$45.00</td>
<td>$52.00</td>
</tr>
<tr>
<td>Bill Peterson</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$42.00</td>
<td>$52.00</td>
</tr>
<tr>
<td>Orest Wowkodaw</td>
<td>Scotiabank</td>
<td>Lowers</td>
<td>Sector Perform</td>
<td>$40.00</td>
<td>$45.00</td>
</tr>
<tr>
<td>Brian MacArthur</td>
<td>Raymond James</td>
<td>Raises</td>
<td>Outperform</td>
<td>$51.00</td>
<td>$49.00</td>
</tr>
<tr>
<td>Bill Peterson</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$52.00</td>
<td>$48.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Freeport-McMoRan. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Freeport-McMoRan compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Freeport-McMoRan's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
For valuable insights into Freeport-McMoRan's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/FCX/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Freeport-McMoRan analyst ratings.</a>
<h2>About Freeport-McMoRan</h2>
Freeport-McMoRan owns stakes in 10 copper mines, led by its 49% ownership of the Grasberg copper and gold operations in Indonesia, 55% of the Cerro Verde mine in Peru, and 72% of Morenci in Arizona. It sold around 1.2 million metric tons of copper (its share) in 2024, making it the one of the world's largest copper miners by volume. It also sold about 900,000 ounces of gold, mostly from Grasberg, and 70 million pounds of molybdenum. It had about 25 years of copper reserves at the end of December 2024. We expect it to sell similar amounts of copper midcycle in 2029, though we expect gold volumes to decline to about 700,000 ounces then due to falling production at Grasberg.
<h3>Key Indicators: Freeport-McMoRan's Financial Health</h3>
Market Capitalization: Boasting an elevated market capitalization, the company surpasses industry averages. This signals substantial size and strong market recognition.
Revenue Challenges: Freeport-McMoRan's revenue growth over 3M faced difficulties. As of 31 March, 2025, the company experienced a decline of approximately -9.38%. This indicates a decrease in top-line earnings. When compared to others in the Materials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Freeport-McMoRan's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of 6.15%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Freeport-McMoRan's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of 2.0%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): Freeport-McMoRan's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of 0.64%, the company may face hurdles in achieving optimal financial returns.
Debt Management: Freeport-McMoRan's debt-to-equity ratio stands notably higher than the industry average, reaching 0.53. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Breaking Down Freeport-McMoRan: 9 Analysts Share Their Views

Target's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TGT#NYSE">TGT</a>) short percent of float has fallen 18.91% since its last report. The company recently reported that it has 16.15 million shares sold short, which is 3.56% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.67 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Target Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1750078832_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Target has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Target's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Target's peer group average for short interest as a percentage of float is 4.53%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Looking Into Target's Recent Short Interest

Kimco Realty's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KIM#NYSE">KIM</a>) short percent of float has fallen 12.77% since its last report. The company recently reported that it has 17.95 million shares sold short, which is 3.62% of all regular shares that are available for trading. Based on its trading volume, it would take traders 4.53 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Kimco Realty Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1750078827_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Kimco Realty has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Kimco Realty's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Kimco Realty's peer group average for short interest as a percentage of float is 5.89%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

What's Driving the Market Sentiment Around Kimco Realty?

Providing a diverse range of perspectives from bullish to bearish, 8 analysts have published ratings on Martin Marietta Materials (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MLM#NYSE">MLM</a>) in the last three months.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for Martin Marietta Materials, revealing an average target of $574.62, a high estimate of $634.00, and a low estimate of $491.00. A decline of 2.96% from the prior average price target is evident in the current average. 
<img src="https://www.benzinga.com/files/images/story/2025/1750078825_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Martin Marietta Materials. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Anthony Codling</td>
<td>RBC Capital</td>
<td>Announces</td>
<td>Sector Perform</td>
<td>$515.00</td>
<td>-</td>
</tr>
<tr>
<td>Steven Fisher</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$634.00</td>
<td>$548.00</td>
</tr>
<tr>
<td>Angel Castillo</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$576.00</td>
<td>$561.00</td>
</tr>
<tr>
<td>Brian Brophy</td>
<td>Stifel</td>
<td>Raises</td>
<td>Buy</td>
<td>$609.00</td>
<td>$559.00</td>
</tr>
<tr>
<td>Patrick Tyler Brown</td>
<td>Raymond James</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$597.00</td>
<td>$600.00</td>
</tr>
<tr>
<td>Steven Fisher</td>
<td>UBS</td>
<td>Announces</td>
<td>Neutral</td>
<td>$491.00</td>
<td>-</td>
</tr>
<tr>
<td>Garik Shmois</td>
<td>Loop Capital</td>
<td>Lowers</td>
<td>Buy</td>
<td>$615.00</td>
<td>$645.00</td>
</tr>
<tr>
<td>Adrian Heurta</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$560.00</td>
<td>$640.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Martin Marietta Materials. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Martin Marietta Materials compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for Martin Marietta Materials's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
For valuable insights into Martin Marietta Materials's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/MLM/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Martin Marietta Materials analyst ratings.</a>
<h2>Discovering Martin Marietta Materials: A Closer Look</h2>
Martin Marietta Materials is one of the United States' largest producer of construction aggregates (crushed stone, sand, and gravel). In 2024, Martin Marietta sold 191 million tons of aggregates. Martin Marietta's most important markets include Texas, Colorado, North Carolina, Georgia, and Florida, accounting for most of its sales. The company also produces cement in Texas and uses its aggregates in its asphalt and ready-mixed concrete businesses. Martin's magnesia specialties business produces magnesia-based chemical products and dolomitic lime.
<h3>Martin Marietta Materials: A Financial Overview</h3>
Market Capitalization Analysis: With an elevated market capitalization, the company stands out above industry averages, showcasing substantial size and market acknowledgment.
Revenue Growth: Martin Marietta Materials's revenue growth over a period of 3M has been noteworthy. As of 31 March, 2025, the company achieved a revenue growth rate of approximately 8.15%. This indicates a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Materials sector.
Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of 8.57%, the company may need to address challenges in effective cost control.
Return on Equity (ROE): Martin Marietta Materials's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of 1.25%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): Martin Marietta Materials's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of 0.65%, the company may face hurdles in achieving optimal financial performance.
Debt Management: With a high debt-to-equity ratio of 0.64, Martin Marietta Materials faces challenges in effectively managing its debt levels, indicating potential financial strain.
<h2>What Are Analyst Ratings?</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Deep Dive Into Martin Marietta Materials Stock: Analyst Perspectives (8 Ratings)

Cleanspark's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLSK#NYSE">CLSK</a>) short percent of float has fallen 3.83% since its last report. The company recently reported that it has 72.21 million shares sold short, which is 26.4% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.41 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Cleanspark Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1750078822_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Cleanspark has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Cleanspark's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Cleanspark's peer group average for short interest as a percentage of float is 14.46%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

CLSK

Looking Into Cleanspark's Recent Short Interest

Throughout the last three months, 14 analysts have evaluated Celanese (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>), offering a diverse set of opinions from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">4</td>
<td align="right">7</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">4</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $60.57, with a high estimate of $76.00 and a low estimate of $40.00. Observing a 0.23% increase, the current average has risen from the previous average price target of $60.43. 
<img src="https://www.benzinga.com/files/images/story/2025/1750078815_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
The analysis of recent analyst actions sheds light on the perception of Celanese by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Michael Sison</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$66.00</td>
<td>$45.00</td>
</tr>
<tr>
<td>John McNulty</td>
<td>BMO Capital</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$55.00</td>
<td>$46.00</td>
</tr>
<tr>
<td>Steve Byrne</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$61.00</td>
<td>$55.00</td>
</tr>
<tr>
<td>Michael Leithead</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$62.00</td>
<td>$59.00</td>
</tr>
<tr>
<td>Jeffrey Hammond</td>
<td>Keybanc</td>
<td>Raises</td>
<td>Overweight</td>
<td>$76.00</td>
<td>$71.00</td>
</tr>
<tr>
<td>Michael Sison</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$45.00</td>
<td>$40.00</td>
</tr>
<tr>
<td>Bradley Thomas</td>
<td>Keybanc</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$71.00</td>
<td>$76.00</td>
</tr>
<tr>
<td>Michael Sison</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$40.00</td>
<td>$55.00</td>
</tr>
<tr>
<td>Joshua Spector</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$46.00</td>
<td>$60.00</td>
</tr>
<tr>
<td>Charles Neivert</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$48.00</td>
<td>$50.00</td>
</tr>
<tr>
<td>Patrick Cunningham</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$52.00</td>
<td>$58.00</td>
</tr>
<tr>
<td>David Begleiter</td>
<td>Deutsche Bank</td>
<td>Raises</td>
<td>Buy</td>
<td>$75.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>Stephen Richardson</td>
<td>Evercore ISI Group</td>
<td>Lowers</td>
<td>In-Line</td>
<td>$75.00</td>
<td>$85.00</td>
</tr>
<tr>
<td>Aleksey Yefremov</td>
<td>Keybanc</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$76.00</td>
<td>$76.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Celanese. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Celanese compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Celanese's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Celanese's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/CE/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Celanese analyst ratings.</a>
<h2>About Celanese</h2>
Celanese is one of the world's largest producers of acetic acid and its downstream derivative chemicals, which are used in various end markets, including coatings and adhesives. The company is also one of the largest producers of specialty polymers, which are used in the automotive, electronics, medical, building, and consumer end markets. The company also makes cellulose derivatives used in cigarette filters.
<h3>A Deep Dive into Celanese's Financials</h3>
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Revenue Challenges: Celanese's revenue growth over 3M faced difficulties. As of 31 March, 2025, the company experienced a decline of approximately -8.5%. This indicates a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Materials sector.
Net Margin: Celanese's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive -0.88% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Celanese's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of -0.41%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): Celanese's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of -0.09%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 2.53, caution is advised due to increased financial risk.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Comments

Dometic Gr

Notizie

Ultime notizie per Dometic Gr (OTC:DTCGF) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO